Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda
Open Access
- 28 November 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 10 (6), 216
- https://doi.org/10.1186/bcr2194
Abstract
Many women newly diagnosed with breast cancer and with a strong family history of breast cancer are referred to a family cancer service for genetic counselling and for consideration of genetic testing for germline mutations in cancer predisposition genes following completion of their cancer treatment. However, there is growing evidence that mutation status may influence treatment recommendations, and that there may be benefits in having 'treatment-focused genetic counselling and testing' available shortly after cancer diagnosis. This article reviews the literature that could inform the development of treatment-focused genetic counselling and testing, including: the rationale for genetic testing to aid with treatment decisions; the potential benefits of using mutation or risk status to tailor management; the criteria that may be used to identify patients most likely to carry germline mutations; and the evidence regarding women's decision-making regarding treatment-focused genetic counselling and testing and the associated psychological impact.Keywords
This publication has 91 references indexed in Scilit:
- Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance ImagingJournal of Clinical Oncology, 2009
- Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologistFamilial Cancer, 2007
- BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapyBreast Cancer Research and Treatment, 2007
- Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancerProceedings of the National Academy of Sciences of the United States of America, 2007
- Prophylactic Mastectomy in BRCA1/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer ClinicAnnals of Surgical Oncology, 2007
- Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancerEuropean Journal Of Cancer, 2006
- Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivorsBreast Cancer Research and Treatment, 2006
- BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relativesEuropean Journal Of Cancer, 2006
- A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patientsEuropean Journal Of Cancer, 2005
- American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer SusceptibilityJournal of Clinical Oncology, 2003